Concepedia

Vladimir Ivanov

VI

Statistics

Publications

9

Citations

992

H-Index

9

Active since

2016

Affiliations

Federal Almazov North-West Medical Research Centre(Current)

Laiko General Hospital of Athens

University Medical Center Hamburg-Eppendorf

University Hospital Kralovske Vinohrady

Universität Hamburg

Vladimir Ivanov is an author at Federal Almazov North-West Medical Research Centre specializing in medicine, chemotherapy, and pharmacotherapy.

ORCID

Publications per year

2016–2022

9

Publications

9

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Andrew H. Wei, Pau Montesinos, Vladimir Ivanov et al. · Blood · 2020 · 756 citations · Full text

, , +9

Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study

Gerald J. Gleich, Florence Roufosse, Geoffrey Chupp et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 44 citations · Full text

, , +13

6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos et al. · Blood Cancer Journal · 2021 · 38 citations · Full text

, , +13

Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos et al. · Blood · 2022 · 38 citations · Full text

, , +7

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

Keith W. Pratz, Panayiotis Panayiotidis, Christian Récher et al. · Blood Cancer Journal · 2022 · 35 citations · Full text

, , +17

1–5 of 9